Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastrointestinal function regulation by nitrergic efferent nerves.

Noboru Toda1, Arnold G Herman

  • 1Toyama Institute for Cardiovascular Pharmacology Research, Azuchi-machi, Chuo-ku, Osaka, Japan. n.toda.toyama-bldg@orion.ocn.ne.jp

Pharmacological Reviews
|August 20, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nitric oxide donor molsidomine favors features of atherosclerotic plaque stability and reduces myocardial infarction in mice.

Vascular pharmacology·2019
Same author

Cigarette smoking impairs nitric oxide-mediated cerebral blood flow increase: Implications for Alzheimer's disease.

Journal of pharmacological sciences·2016
Same author

Hyperhomocysteinemia impairs regional blood flow: involvements of endothelial and neuronal nitric oxide.

Pflugers Archiv : European journal of physiology·2016
Same author

Recent advances in research on nitrergic nerve-mediated vasodilatation.

Pflugers Archiv : European journal of physiology·2014
Same author

Obesity-induced cerebral hypoperfusion derived from endothelial dysfunction: one of the risk factors for Alzheimer's disease.

Current Alzheimer research·2014
Same author

Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death.

European heart journal·2014
Same journal

Aryl hydrocarbon receptor pharmacology-mechanisms, ligands, and therapeutic potential.

Pharmacological reviews·2026
Same journal

Mast cell proteases and their significance in physiology, pathology, and therapeutic approaches.

Pharmacological reviews·2026
Same journal

Translational medications development for methamphetamine use disorder: A systematic review of preclinical, human laboratory, and clinical research.

Pharmacological reviews·2026
Same journal

Reharnessing the therapeutic potential of gallium-based compounds in oncology: From the laboratory to the clinic.

Pharmacological reviews·2026
Same journal

Pharmacogenomics of antibacterial and antiviral therapies: Clinical actionability, evidence gaps, and future directions.

Pharmacological reviews·2026
Same journal

International Union of Basic and Clinical Pharmacology. CXXII. Applying an objective evaluation to the status of class A orphan G protein-coupled receptors.

Pharmacological reviews·2026
See all related articles

Nitric oxide (NO) acts as a key inhibitory neurotransmitter in the gastrointestinal tract, regulating smooth muscle functions. Understanding nitrergic nerves offers new therapeutic avenues for GI diseases.

Area of Science:

  • Neurogastroenterology
  • Physiology
  • Pharmacology

Background:

  • Nonadrenergic noncholinergic inhibitory nerves control GI smooth muscle.
  • Nitric oxide (NO) is a gaseous neurotransmitter involved in these responses.
  • Nitrergic nerves play crucial roles in GI motility and secretion.

Purpose of the Study:

  • To review the discovery and function of nitrergic nerves in the GI tract.
  • To explore the mechanisms of NO-mediated smooth muscle relaxation.
  • To discuss the pathological implications and therapeutic potential of nitrergic pathways.

Main Methods:

  • Literature review of studies on nitrergic innervation.
  • Analysis of NO synthase inhibitors' role.
  • Examination of NO signaling pathways (cGMP-dependent and independent).

Related Experiment Videos

Main Results:

  • NO is identified as a major inhibitory neurotransmitter in the GI tract.
  • Nitrergic nerves regulate smooth muscle tone, motility, and fluid secretion.
  • NO-induced relaxation involves both cGMP-dependent and independent mechanisms.

Conclusions:

  • Nitric oxide is a critical neurotransmitter in GI function.
  • Dysregulation of nitrergic pathways may contribute to GI pathophysiology.
  • Targeting nitrergic mechanisms holds promise for novel GI disease therapies.